Callejas Rubio, José LuisRíos Fernández, RaquelDe la Hera Fernández, Javier2023-05-032023-05-032021-05-27http://hdl.handle.net/10668/22359enAntibodies, ViralCOVID-19COVID-19 VaccinesGiant Cell ArteritisHumansSARS-CoV-2Efficacy and safety of SARS-CoV-2 vaccine in patients with giant cell arteritis.Eficacia y seguridad de la vacuna frente a SARS-CoV-2 en pacientes con arteritis de células gigantes.research article34119341open access10.1016/j.medcli.2021.05.0031578-8989PMC8157119https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157119https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157119/pdf